US Patent Issued to Cedars-Sinai Medical Center on Feb. 10 for "Diagnosis of inflammatory bowel disease based on genes" (California Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,959, issued on Feb. 10, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Diagnosis of inflammatory bowel disease based on genes" was invented by Dermot P. McGovern (Los Angeles) and Dalin Li (Walnut, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention describes a method of prognosing high or low probability of developing an inflammatory bowel disease (IBD) in a subject and a method of diagnosing an inflammatory bowel disease (IBD) in a subject. The invention further provides for a method of identifying genes/genetic loci associated with a disease condition, such as IBD, CD and/or UC."

The patent was filed on Dec. ...